XBI icon

SPDR S&P Biotech ETF

702 hedge funds and large institutions have $6.3B invested in SPDR S&P Biotech ETF in 2022 Q2 according to their latest regulatory filings, with 121 funds opening new positions, 249 increasing their positions, 196 reducing their positions, and 110 closing their positions.

Holders
702
Holders Change
+3
Holders Change %
+0.43%
% of All Funds
11.87%
Holding in Top 10
32
Holding in Top 10 Change
+12
Holding in Top 10 Change %
+60%
% of All Funds
0.54%
New
121
Increased
249
Reduced
196
Closed
110
Calls
$1.8B
Puts
$1.78B
Net Calls
+$26.7M
Net Calls Change
-$52.4M
Name Market Value Shares Shares
Change
Shares
Change %
CT
801
Cambridge Trust
Massachusetts
-98 Closed
ACA
802
Atlas Capital Advisors
Wyoming
-97 Closed
LAS
803
Lloyd Advisory Services
Georgia
-80 Closed
WCAMG
804
Woodard & Company Asset Management Group
North Carolina
-75 Closed
MFA
805
McClarren Financial Advisors
Pennsylvania
-60 Closed
SW
806
SVB Wealth
Massachusetts
-60 Closed
TFA
807
Toth Financial Advisory
Virginia
-30 Closed
FPS
808
Fieldpoint Private Securities
Connecticut
-22 Closed
CPW
809
Crestmont Private Wealth
Texas
-21 Closed
HR
810
Howe & Rusling
New York
-18 Closed
Koshinski Asset Management
811
Koshinski Asset Management
Illinois
-12 Closed
CTB
812
Country Trust Bank
Illinois
-8 Closed
LSA
813
Lansing Street Advisors
Pennsylvania
-4 Closed
ACM
814
Atika Capital Management
New York
Capital Fund Management (CFM)
815
Capital Fund Management (CFM)
France
CAC
816
Cowen and Company
New York
Nomura Holdings
817
Nomura Holdings
Japan
DCM
818
Driehaus Capital Management
Illinois
CAM
819
Cormorant Asset Management
Massachusetts
TM
820
Triatomic Management
California
EIM
821
Elliott Investment Management
Florida
CC
822
Centiva Capital
New York
CWP
823
Concord Wealth Partners
Virginia
$0 5
AC
824
Antara Capital
New York
SI
825
Sofinnova Investments
California